Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK Hospitals.

Ashcroft DM, Lewis PJ, Tully MP, Farragher TM, Taylor D, Wass V, Williams SD, Dornan T.

Drug Saf. 2015 Sep;38(9):833-43. doi: 10.1007/s40264-015-0320-x.

2.

Injecting drug use in prison: prevalence and implications for needle exchange policy.

Wright NM, Tompkins CN, Farragher TM.

Int J Prison Health. 2015;11(1):17-29. doi: 10.1108/IJPH-09-2014-0032.

PMID:
25751704
3.

Geographical inequalities in uptake of NHS-funded eye examinations: small area analysis of Leeds, UK.

Shickle D, Farragher TM.

J Public Health (Oxf). 2015 Jun;37(2):337-45. doi: 10.1093/pubmed/fdu039. Epub 2014 Jul 11.

4.

Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Pereira JB, Farragher TM, Tully MP, Jonathan Cooke J.

Br J Clin Pharmacol. 2014 May;77(5):896-903.

5.

Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.

Mirjafari H, Farragher TM, Verstappen SM, Yates A, Bunn D, Marshall T, Lunt M, Symmons DP, Bruce IN.

Arthritis Res Ther. 2011;13(5):R159. doi: 10.1186/ar3476. Epub 2011 Sep 29.

6.

The relationship between oral contraceptive use and functional outcome in women with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.

Camacho EM, Lunt M, Farragher TM, Verstappen SM, Bunn DK, Symmons DP.

Arthritis Rheum. 2011 Aug;63(8):2183-91. doi: 10.1002/art.30416.

7.

Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register.

Camacho EM, Harrison M, Farragher TM, Lunt M, Bunn DK, Verstappen SM, Symmons DP.

Ann Rheum Dis. 2011 Apr;70(4):642-5. doi: 10.1136/ard.2010.140301.

8.

The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.

Camacho EM, Farragher TM, Lunt M, Verstappen SM, Bunn D, Symmons DP.

Ann Rheum Dis. 2010 Oct;69(10):1834-7. doi: 10.1136/ard.2010.128769. Epub 2010 Jun 25.

9.

Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis.

Franklin J, Farragher TM, Lunt M, Camacho EM, Bunn D, Marshall T, Symmons DP.

Ann Rheum Dis. 2010 Sep;69(9):1660-4. doi: 10.1136/ard.2009.121871. Epub 2010 May 24.

10.

Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients.

Farragher TM, Plant D, Flynn E, Eyre S, Bunn D, Thomson W, Symmons D, Barton A.

Arthritis Care Res (Hoboken). 2010 May;62(5):676-82. doi: 10.1002/acr.20208.

11.

Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.

Farragher TM, Lunt M, Plant D, Bunn DK, Barton A, Symmons DP.

Arthritis Care Res (Hoboken). 2010 May;62(5):664-75. doi: 10.1002/acr.20207.

12.

Risk factors for onset of chronic oro-facial pain--results of the North Cheshire oro-facial pain prospective population study.

Aggarwal VR, Macfarlane GJ, Farragher TM, McBeth J.

Pain. 2010 May;149(2):354-9. doi: 10.1016/j.pain.2010.02.040. Epub 2010 Mar 20.

13.

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.

Lord PA, Farragher TM, Lunt M, Watson KD, Symmons DP, Hyrich KL; BSR Biologics Register.

Rheumatology (Oxford). 2010 Mar;49(3):563-70. doi: 10.1093/rheumatology/kep422. Epub 2009 Dec 23.

14.

Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.

Farragher TM, Lunt M, Fu B, Bunn D, Symmons DP.

Ann Rheum Dis. 2010 Apr;69(4):689-95. doi: 10.1136/ard.2009.108639. Epub 2009 Oct 26.

15.

Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis.

Harrison MJ, Farragher TM, Clarke AM, Manning SC, Bunn DK, Symmons DP.

Arthritis Rheum. 2009 Oct 15;61(10):1297-304. doi: 10.1002/art.24830.

16.

Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.

Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Farragher TM, Verstappen SM, Hassell A, Symmons DP.

Value Health. 2009 Sep;12(6):1026-34. doi: 10.1111/j.1524-4733.2009.00565.x. Epub 2009 May 15.

17.

Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis.

Goodson NJ, Farragher TM, Symmons DP.

J Rheumatol. 2008 Jun;35(6):945-9. No abstract available.

18.

The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis.

Naz SM, Farragher TM, Bunn DK, Symmons DP, Bruce IN.

Arthritis Rheum. 2008 Apr;58(4):985-9. doi: 10.1002/art.23402.

19.

Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis.

Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, Barton A.

Arthritis Rheum. 2008 Feb;58(2):359-69. doi: 10.1002/art.23149.

20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk